GRI
GRI Bio (GRI)
NASDAQ
$2.05+$0.04 (+2.19%)
Price as of Jun 03, 2026 6:27 PM EDT
  • $3.6M
    Market Cap
  • -94.68%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-6.8M
+80.97%
-3.8M
+16.58%
-3.2M
+176.24%
-1.2M
-77.44%
Depreciation and Amortization Expense
4,000
0.00%
4,000
0.00%
4,000
N/A
N/A
N/A
Total Operating Expenses
12.0M
+45.44%
8.2M
-27.68%
11.4M
+64.36%
6.9M
-25.18%
Operating Profit
-12.0M
+45.44%
-8.2M
-27.68%
-11.4M
+64.36%
-6.9M
-25.18%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
-2.1M
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
+100.00%
-2.1M
N/A
0
+100.00%
Total Nonoperating Income and Expense
21,000
N/A
0
-100.00%
250,000
N/A
0
-100.00%
Income before Taxes
-12.0M
+18.17%
-10.1M
-11.14%
-11.4M
+64.36%
-6.9M
-25.18%
Income Taxes
3,000
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-12.0M
+45.68%
-8.2M
-37.05%
-13.0M
+85.61%
-7.0M
-24.50%
Net Income from Continuing Operations Applicable to Common
-12.0M
+18.17%
-10.1M
-22.39%
-13.0M
+85.61%
-7.0M
-24.50%
Basic EPS and Net Income
-121.80
+120.61%
-55.21
+95.43%
-28.25
+3,994.20%
-0.69
-51.41%
Diluted EPS and Net Income
-121.80
+120.61%
-55.21
+95.43%
-28.25
+3,994.20%
-0.69
-51.41%
Basic Weighted Average Shares
98,162
-46.44%
183,278
-60.29%
461,566
-95.45%
10.1M
+55.07%
Diluted Weighted Average Shares
98,162
-46.44%
183,278
-60.29%
461,566
-95.45%
10.1M
+55.07%
Balance Sheet
Cash and Cash Equivalents
8.2M
+63.66%
5.0M
+178.10%
1.8M
-52.18%
3.8M
+2.13%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
0
-100.00%
Cash and Cash Equivalents and Short-Term Investments
8.2M
+63.66%
5.0M
+178.10%
1.8M
-52.18%
3.8M
-49.65%
Total Current Assets
8.6M
+53.02%
5.6M
+91.38%
2.9M
-29.34%
4.2M
-48.92%
Accumulated Depreciation
34,000
+13.33%
30,000
+15.38%
26,000
N/A
N/A
N/A
Property and Plant and Equipment and Net
3,000
-25.00%
4,000
-50.00%
8,000
N/A
N/A
N/A
Total Long-Term Assets
3,000
-25.00%
4,000
-50.00%
8,000
N/A
0
-100.00%
Total Assets
8.7M
+51.00%
5.7M
+94.15%
3.0M
-28.81%
4.2M
-50.19%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
0
N/A
N/A
N/A
Total Current Liabilities
2.6M
+61.55%
1.6M
-39.34%
2.7M
+49.01%
1.8M
-25.97%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
15,000
-78.87%
71,000
+2,266.67%
3,000
N/A
0
-100.00%
Total Liabilities
2.7M
+55.71%
1.7M
-36.71%
2.7M
+49.01%
1.8M
-28.09%
Retained Earnings
-51.7M
+30.09%
-39.7M
+26.03%
-31.5M
+9.01%
-28.9M
+32.07%
Total Stockholders Equity
6.0M
+49.01%
4.0M
+1,456.76%
259,000
-88.94%
2.3M
-59.75%
Total Shares Outstanding
497,693
-5.29%
525,485
-18.62%
645,738
-95.21%
13.5M
+97.90%
Cash Flow
Cash from Operating Activities
-10.2M
+18.29%
-8.6M
-4.22%
-9.0M
+26.00%
-7.1M
-14.16%
Capital Expenditures
3,000
N/A
0
-100.00%
8,000
N/A
N/A
N/A
Cash from Investing Activities
-3,000
N/A
0
+100.00%
-8,000
-100.21%
3.8M
+198.44%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
13.4M
+13.18%
11.8M
+9.58%
10.8M
+214.60%
3.4M
-78.21%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-166.00%
-12.07%
-188.78%
-48.54%
-366.83%
+226.06%
-112.50%
N/A
Return on Equity
-238.17%
-37.74%
-382.52%
-61.84%
-1,002.46%
+482.29%
-172.16%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
3.25
-5.28%
3.43
+215.49%
1.09
-52.57%
2.29
N/A
Cash Ratio
3.11
+1.31%
3.07
+358.43%
0.67
-67.91%
2.09
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow